Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study

Henit Yanai, Iris Dotan

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)539-540
Number of pages2
JournalJournal of Crohn's and Colitis
Issue number5
StatePublished - 1 May 2019
Externally publishedYes

Cite this